Difference between revisions of "Team:Technion Israel/Project/Overview"
| Line 10: | Line 10: | ||
background-color: rgb(255, 184, 106); | background-color: rgb(255, 184, 106); | ||
} | } | ||
| + | header{background-image: url("https://static.igem.org/mediawiki/2015/f/fc/Technion_Israel_2015_heading_Project_overview.jpg"); background-size: 100%; background-repeat: no-repeat; width: 100%; height: 300px;} | ||
| + | header h1{ color: rgb(255, 184, 106); font-size: 70px;} | ||
| + | |||
| + | #label{font-style: bold; font-family: sans-serif; font-style: Arial; text-shadow:4px 4px navy; height: 300px; line-height: 80px; width: 100%; text-align: center; vertical-align: center;} | ||
</style> | </style> | ||
<title>Team: Technion 2015</title> | <title>Team: Technion 2015</title> | ||
| Line 62: | Line 66: | ||
<div class="content"> | <div class="content"> | ||
| + | <header> | ||
| + | <div id="label"> | ||
| + | <br><h1>Project Overview</h1> | ||
| + | </div> | ||
| + | </header> | ||
<h1 class="abstract_title">Hello! Welcome to our temporary wiki page!</h1> | <h1 class="abstract_title">Hello! Welcome to our temporary wiki page!</h1> | ||
<div class="abstract"> | <div class="abstract"> | ||
Revision as of 19:36, 15 September 2015
Project Overview
Hello! Welcome to our temporary wiki page!
Hair loss affects roughly 61 million people in the United States. More than 95% of hair thinning in men is attributed to male pattern baldness, or androgenetic alopecia. The hair loss product market is a multi-billion dollar market: in the United States alone, this market’s annual revenue is 7 billion dollars, with 3.5% annual growth rate from 2007 to 2012, yet a sufficient solution has yet to be made available. The trigger for androgenetic alopecia is believed to be dihydrotestosterone (DHT), a derivative of testosterone. This summer, we are engineering Bacillus Subtilis, a model organism for a bacterium found naturally on the scalp, to secrete 3?-hydroxysteroid dehydrogenase (3-?-HSD). This enzyme reduces DHT to a non-steroidically active compound, using NADPH and NADH as cofactors.
Our project consists of 3 main parts: 3-?-HSD secretion by the bacterium, engineered bacterium for NADPH overproduction, and a comb as a tool to create a user-friendly experience. By synchronizing these parts, we hope to be able to show convincing evidence of DHT breakdown, providing a promising platform for treatment of male pattern baldness!